12 not yet recruiting, 8 recruiting, 6 completed, 1 active not recruiting. 6 Not applicable, 5 Phase 2, 4 Phase 4, 2 Phase 3, 1 Phase 1.
Follow Sickle Cell Disease (SCD): new trials by email Literature Review of Sickle Cell Disease (SCD) trials Research Report on Sickle Cell Disease (SCD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Self-administered Acupressure in Patients With Sickle Cell Disease Verum Acupressure (using AcuWand), Sham Acupressure (using AcuWand) - Sickle Cell Disease (SCD) | Not applicable | Not yet recruiting | University of Cincinnati | 300 | 2027-10-01 | 2026-10-15 |
| Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease Individuation and Perspective-Taking (IPT), pediatric SCD pain management education session - Sickle Cell Disease, Sickle Cell Anemia in Children | Not applicable | Not yet recruiting | Connecticut Children's Medical Center | 30 | 2027-09-01 | 2026-04-29 |
| Buprenorphine for the Management of Pain in Children With Sickle Cell Disease Buprenorphine Buccal Film [Belbuca] - Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis | Phase 1 | Not yet recruiting | Natasha Archer | 25 | 2027-01-01 | 2026-11-04 |
| Omega-3-Fatty Acids in Children With Sickle Cell Disease Flaxseed - Sickle Cell Disease (SCD) | Not applicable | Not yet recruiting | University of Alabama at Birmingham | 20 | 2026-12-01 | 2026-08-21 |
| MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT) Antiphospholipid (aPL)-Positive, Rheumatic Arthritis | Not yet recruiting | Axiom Bioregistry | 5000 | 2026-10-18 | 2026-10-23 | |
| CPAP for Hypoxemic Acute Chest Syndrome in Sickle Cell Disease O2+CPAP group - Sickle Cell Disease (SCD), Acute Chest Syndrome (ACS) | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 140 | 2026-09-01 | 2026-07-23 |
| Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Severe Sickle Cell Disease Patients standard of care - Sickle Cell Disease (SCD), Vaso-occlusive Events | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 30 | 2026-09-01 | 2026-08-07 |
| Pleuropulmonary Ultrasound Imaging in Patients With Sickle Cell Disease in a Vaso-occlusive Crisis. "ECHODREP" Pleuropulmonary ultrasound - Sickle Cell Disease (SCD), Vaso-Occlusive Crises | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 200 | 2026-09-01 | 2026-08-24 | |
| Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis Standardized Low-dose bolus IV Ketamine within 30 minutes of arrival and every 1 hour as needed for max of 3 doses., Standard Care (in control arm) - Vaso-Occlusive Pain Episode in Sickle Cell Disease, Sickle Cell Disease (SCD) | Phase 4 | Not yet recruiting | University of Mississippi Medical Center | 400 | 2026-08-01 | 2026-07-06 |
| Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire Gazelle-Multispectral point of care testing for newborn sickle cell disease screening; and initiation of early comprehensive clinical interventions - Sickle Cell Disease (SCD) | Phase 4 | Recruiting | Swiss Tropical & Public Health Institute | 120 | 2026-07-27 | 2026-10-05 |
| Epidemiology of Invasive Bacterial Infections in Children With Sickle Cell Disease in France Between 2020 and 2025 Sickle Cell Disease (SCD), Invasive Bacterial Infections | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 350 | 2026-07-15 | 2026-06-10 | |
| Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia Pharmacokinetic based dosage change, Pharmacokinetic dosing - Sickle Cell Disease (SCD) | Phase 2 / Phase 3 | Recruiting | Yves Pastore | 29 | 2026-02-03 | 2026-08-21 |
| Megakaryocyte Heterogeneity in Sickle Cell Disease Sickle Cell Disease (SCD) | Not yet recruiting | Centre Hospitalier Universitaire de la Guadeloupe | 100 | 2025-07-01 | 2025-05-25 | |
| Exploratory Study on Global Reflexology in Sickle Cell Disease Global reflexology - Sickle Cell Disease (SCD) | Not applicable | Recruiting | Hospices Civils de Lyon | 30 | 2025-06-30 | 2025-07-08 |
| Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease Depot medroxyprogesterone acetate (DMPA) - Sickle Cell Disease (SCD), Vaso-Occlusive Pain Episode in Sickle Cell Disease | Phase 4 | Recruiting | University of Pennsylvania | 65 | 2025-06-26 | 2026-11-05 |
| Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient Sickle Cell Disease (SCD) | Recruiting | University Hospital, Toulouse | 40 | 2025-03-13 | 2025-03-20 | |
| Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation blood sampling - Sickle Cell Disease (SCD) | Not yet recruiting | Hospices Civils de Lyon | 200 | 2025-02-01 | 2025-01-15 | |
| Sickle Cell Kidney Biorepository Sickle Cell Trait, Sickle Cell Disease (SCD) | Recruiting | University of Texas Southwestern Medical Center | 800 | 2024-08-22 | 2026-04-13 | |
| Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease Sickle Cell Disease (SCD) | Recruiting | University of Rochester | 480 | 2024-06-01 | 2026-06-04 | |
| Hemoglobin Disorders in Egypt: Sickle Cell Disease Ain Shams University Institutional Registry Sickle Cell Disease (SCD) | Recruiting | Ain Shams University | 400 | 2024-03-17 | 2026-09-02 |
Showing 20 of 28. Sign in to see all of them.
Anemia, Sickle Cell (28) · Vaso-Occlusive Crises (7) · Acute Chest Syndrome (3) · Hemoglobin SC Disease (3) · Pain (2) · Pneumonia (2) · Renal Insufficiency, Chronic (2) · Sickle Cell Trait (2) · Acute Pain (1) · Albuminuria (1) · Asthma (1) · COVID-19 (1) · Celiac Disease (1) · Chest Pain (1) · Crohn Disease (1)
Anemia (28) · Anemia, Hemolytic (28) · Anemia, Hemolytic, Congenital (28) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (28) · Genetic Diseases, Inborn (28) · Hemic and Lymphatic Diseases (28) · Hemoglobinopathies (28) · Hematologic Diseases (27) · Pathological Conditions, Signs and Symptoms (8) · Lung Diseases (5) · Pathologic Processes (5) · Respiratory Tract Diseases (5) · Signs and Symptoms (5) · Disease Attributes (4) · Female Urogenital Diseases (4)
crizanlizumab (4) · Standard of Care (3) · Blood Specimen Collection (1) · Buprenorphine (1) · Health Services Needs and Demand (1) · Linseed Oil (1)
Novartis Pharmaceuticals (5) · Assistance Publique - Hôpitaux de Paris (4) · Hospices Civils de Lyon (2) · Ain Shams University (1) · Alexion Pharmaceuticals, Inc. (1) · Axiom Bioregistry (1) · Centre Hospitalier Universitaire de la Guadeloupe (1) · Connecticut Children's Medical Center (1) · Natasha Archer (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Swiss Tropical & Public Health Institute (1) · University Hospital, Toulouse (1) · University of Alabama at Birmingham (1) · University of Cincinnati (1) · University of Maryland, Baltimore (1)
United States (14) · France (8) · Canada (4) · Brazil (3) · India (3) · Lebanon (3) · Spain (3) · Turkey (Türkiye) (3) · United Kingdom (3) · Belgium (2) · Colombia (2) · Germany (2) · Greece (2) · Italy (2) · Jordan (2)
Andrea Roe, MD MPH (1) · Arun S Shet, M.D. (1) · John N Freeman, MD (1) · Natasha Archer, MD (1) · Siddika Mulchan, PsyD (1) · Veronique Baccini, MD PhD (1)
PMID 37254256, PMID 21584938, PMID 31730182, PMID 33275672, PMID 34922648, PMID 36355805, PMID 36529836, PMID 36904244, PMID 39497751, PMID 40088922, PMID 40569673
2017 (2), 2018 (1), K23HL175237 (1), R01HL175726 (1)